126 related articles for article (PubMed ID: 11113721)
1. Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M
Eur J Heart Fail; 2000 Dec; 2(4):431-7. PubMed ID: 11113721
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
Zapfe jun G
Phytomedicine; 2001 Jul; 8(4):262-6. PubMed ID: 11515715
[TBL] [Abstract][Full Text] [Related]
3. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
4. Benefit-Risk Assessment of Crataegus Extract WSÂ 1442: An Evidence-Based Review.
Holubarsch CJF; Colucci WS; Eha J
Am J Cardiovasc Drugs; 2018 Feb; 18(1):25-36. PubMed ID: 29080984
[TBL] [Abstract][Full Text] [Related]
5. Health effects of hawthorn.
Dahmer S; Scott E
Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
[TBL] [Abstract][Full Text] [Related]
7. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
[TBL] [Abstract][Full Text] [Related]
8. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
Degenring FH; Suter A; Weber M; Saller R
Phytomedicine; 2003; 10(5):363-9. PubMed ID: 12833999
[TBL] [Abstract][Full Text] [Related]
9. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study].
Leuchtgens H
Fortschr Med; 1993 Jul; 111(20-21):352-4. PubMed ID: 8375791
[TBL] [Abstract][Full Text] [Related]
10. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J
Fortschr Med; 1996 Aug; 114(24):291-6. PubMed ID: 8974970
[TBL] [Abstract][Full Text] [Related]
11. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion.
Veveris M; Koch E; Chatterjee SS
Life Sci; 2004 Feb; 74(15):1945-55. PubMed ID: 14761675
[TBL] [Abstract][Full Text] [Related]
12. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
13. Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences.
Zorniak M; Szydlo B; Krzeminski TF
J Physiol Pharmacol; 2017 Aug; 68(4):521-526. PubMed ID: 29151068
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure.
Tauchert M
Am Heart J; 2002 May; 143(5):910-5. PubMed ID: 12040357
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
Maulik SK; Wilson V; Seth S; Bhargava B; Dua P; Ramakrishnan S; Katiyar CK
Phytomedicine; 2016 Oct; 23(11):1211-9. PubMed ID: 26988798
[TBL] [Abstract][Full Text] [Related]
16. [Hawthorn extract WS 1442 in the treatment of patients with heart failure and LVEF of 25%-35%].
Von Holubarsch CJ; Niestroj M; Wassmer A; Gaus W; Meinertz T
MMW Fortschr Med; 2010 Jul; 152 Suppl 2():56-61. PubMed ID: 21591320
[No Abstract] [Full Text] [Related]
17. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure].
Tauchert M; Gildor A; Lipinski J
Herz; 1999 Oct; 24(6):465-74; discussion 475. PubMed ID: 10546150
[TBL] [Abstract][Full Text] [Related]
18. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
Pittler MH; Schmidt K; Ernst E
Am J Med; 2003 Jun; 114(8):665-74. PubMed ID: 12798455
[TBL] [Abstract][Full Text] [Related]
19. Effects of hawthorn on the progression of heart failure in a rat model of aortic constriction.
Hwang HS; Boluyt MO; Converso K; Russell MW; Bleske BE
Pharmacotherapy; 2009 Jun; 29(6):639-48. PubMed ID: 19476417
[TBL] [Abstract][Full Text] [Related]
20. The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure.
Zick SM; Gillespie B; Aaronson KD
Eur J Heart Fail; 2008 Jun; 10(6):587-93. PubMed ID: 18490196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
